217 related articles for article (PubMed ID: 3304898)
21. A comparison of the pharmacokinetics and metabolic effects of human regular and NPH insulin mixtures.
Davis SN; Thompson CJ; Brown MD; Home PD; Alberti KG
Diabetes Res Clin Pract; 1991 Aug; 13(1-2):107-17. PubMed ID: 1773708
[TBL] [Abstract][Full Text] [Related]
22. Mixing insulins in 1990.
Anderson JH; Campbell RK
Diabetes Educ; 1990; 16(5):380-7. PubMed ID: 2202572
[TBL] [Abstract][Full Text] [Related]
23. Effects of mixing short- and intermediate-acting insulins on absorption course and biologic effect of short-acting preparation.
Forlani G; Santacroce G; Ciavarella A; Capelli M; Mattioli L; Vannini P
Diabetes Care; 1986; 9(6):587-90. PubMed ID: 3542453
[TBL] [Abstract][Full Text] [Related]
24. Subcutaneous insulin substitution in insulin-dependent diabetes mellitus. Pharmacokinetic and pharmacodynamic studies.
Olsson PO
Acta Med Scand Suppl; 1987; 718():1-78. PubMed ID: 3321929
[TBL] [Abstract][Full Text] [Related]
25. Miscibility of semisynthetic human ultralente insulin with short-acting insulin in insulin-dependent diabetic patients.
Lunetta M; di Mauro M; Crimi S; Sudano L; Mughini L
Acta Diabetol Lat; 1988; 25(3):263-9. PubMed ID: 3071068
[TBL] [Abstract][Full Text] [Related]
26. Absorption kinetics of regular, isophane, and protamine zinc insulin in normal cats.
Wallace MS; Peterson ME; Nichols CE
Domest Anim Endocrinol; 1990 Oct; 7(4):509-15. PubMed ID: 2261761
[TBL] [Abstract][Full Text] [Related]
27. Basal activity profiles of NPH and [Nepsilon-palmitoyl Lys (B29)] human insulins in subjects with IDDM.
Radziuk J; Pye S; Bradley B; Braaten J; Vignati L; Roach P; Bowsher R; DiMarchi R; Chance R
Diabetologia; 1998 Jan; 41(1):116-20. PubMed ID: 9498640
[TBL] [Abstract][Full Text] [Related]
28. Optimal provision of daytime NPH insulin in patients using the insulin analog lispro.
Ahmed AB; Home PD
Diabetes Care; 1998 Oct; 21(10):1707-13. PubMed ID: 9773735
[TBL] [Abstract][Full Text] [Related]
29. Effects of the anatomical region used for insulin injections on glycemia in type I diabetes subjects.
Bantle JP; Neal L; Frankamp LM
Diabetes Care; 1993 Dec; 16(12):1592-7. PubMed ID: 8299455
[TBL] [Abstract][Full Text] [Related]
30. Comparison of blood glucose profile and glycemic control in type 1 diabetic patients treated with Actrapid-Monotard or Actrapid Protaphane (NPH) human insulins.
Buysschaert M; Minette P; Ketelslegers JM; Pairet JV; Vogels M; Lambert AE
Diabetes Res; 1987 Jan; 4(1):31-3. PubMed ID: 3552364
[TBL] [Abstract][Full Text] [Related]
31. Twice-daily mixed regular and NPH insulin injections with new jet injector versus conventional syringes: pharmacokinetics of insulin absorption.
Hallé JP; Lambert J; Lindmayer I; Menassa K; Coutu F; Moghrabi A; Legendre L; Legault C; Lalumière G
Diabetes Care; 1986; 9(3):279-82. PubMed ID: 3525057
[TBL] [Abstract][Full Text] [Related]
32. Nocturnal glucose metabolism after bedtime injection of insulin glargine or neutral protamine hagedorn insulin in patients with type 2 diabetes.
Linn T; Fischer B; Soydan N; Eckhard M; Ehl J; Kunz C; Bretzel RG
J Clin Endocrinol Metab; 2008 Oct; 93(10):3839-46. PubMed ID: 18611975
[TBL] [Abstract][Full Text] [Related]
33. Absorption kinetics of regular and isophane (NPH) insulin in the normal dog.
Goeders LA; Esposito LA; Peterson ME
Domest Anim Endocrinol; 1987 Jan; 4(1):43-50. PubMed ID: 3333933
[TBL] [Abstract][Full Text] [Related]
34. Optimization of evening insulin dose in patients using the short-acting insulin analog lispro.
Ahmed AB; Mallias J; Home PD
Diabetes Care; 1998 Jul; 21(7):1162-6. PubMed ID: 9653613
[TBL] [Abstract][Full Text] [Related]
35. Effect of storage temperature of insulin on pharmacokinetics and pharmacodynamics of insulin mixtures injected subcutaneously in subjects with type 1 (insulin-dependent) diabetes mellitus.
Perriello G; Torlone E; Di Santo S; Fanelli C; De Feo P; Santeusanio F; Brunetti P; Bolli GB
Diabetologia; 1988 Nov; 31(11):811-5. PubMed ID: 3069528
[TBL] [Abstract][Full Text] [Related]
36. Premixed insulin at ratio 3/7 and regular + isophane insulins at mixing ratios from 2/8 to 4/6 achieve the same metabolic control.
Cucinotta D; Mannino D; Lasco A; Di Cesare E; Musolino C; Alessi R
Diabete Metab; 1991; 17(1):49-54. PubMed ID: 1868960
[TBL] [Abstract][Full Text] [Related]
37. Improvement in morning hyperglycaemia with basal human ultratard and prandial human actrapid insulin--a comparison of multiple injection regimens.
Davies RR; McEwen J; Moreland TA; Durnin C; Newton RW
Diabet Med; 1988 Oct; 5(7):671-5. PubMed ID: 2975553
[TBL] [Abstract][Full Text] [Related]
38. The effect of insulin mixtures in type I diabetics: influence of the intermediate acting insulin on the action of short acting insulin.
Goicolea I; Quiroga A; Vazquez JA
Diabete Metab; 1987; 13(4):467-70. PubMed ID: 3315768
[TBL] [Abstract][Full Text] [Related]
39. Soluble and Lente human insulin mixtures in normal man.
Owens DR; Vora JP; Jones IR; Birtwell J; Atiea J; Luzio S; Williams S
Diabetes Res; 1988 Jan; 7(1):35-40. PubMed ID: 3042252
[TBL] [Abstract][Full Text] [Related]
40. The effect of mixing human soluble and human crystalline zinc-suspension insulin: plasma insulin and blood glucose profiles after subcutaneous injection.
Francis AJ; Hanning I; Alberti KG
Diabet Med; 1985 May; 2(3):177-80. PubMed ID: 2952414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
